郑州近视能不能做手术-【郑州视献眼科医院】,郑州视献眼科医院,郑州近视激光手术最高多少度,郑州小儿弱视的治疗方法,郑州女兵近视,郑州附近的眼科医院在哪,郑州做斜视手术多少钱,郑州开封眼病医院激光近视

BEIJING, Feb. 8 (Xinhua) -- Forty people died in more than 118,000 cases of fire reported across China from February 2 to February 8, as Chinese revelers celebrated the Lunar New Year holiday with fireworks, according to a statement released Tuesday by the country's Ministry of Public Security.The number of cases jumped from the 7,480 fires reported during last year's Spring Festival holiday, which caused losses worth 28.5 million yuan. The incidents also injured 37 people and caused more than 56 million yuan (8.5 million U.S. dollars) in damages, which is almost double the figure from last year.However, this year's losses did not include a case in northeastern Liaoning Province where a five-star hotel in the city of Shenyang was set ablaze by fireworks on February 3.The fire, which caused no casualties, is possibly the country's largest fireworks accident during this year's Spring Festival celebrations.According to the statement, some 260,000 police and fire fighters across the country were mobilized for 24,800 fire control missions.The personnel rescued more than 1,600 people and evacuated tens of thousands. Fire departments have been strengthening monitoring of high-rise buildings, shopping malls, markets, construction sites and other crowded or vulnerable locations.Also, a total of 173 companies were suspended from operating for failing to meet fire prevention and control standards, according to the ministry.
WASHINGTON, May 11 (Xinhua) -- Johns Hopkins University researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.The work, published Wednesday in the journal Science Translational Medicine, suggests that liver cells derived from so- called "induced-pluripotent stem cells (iPSCs)" could one day be used as an alternative to liver transplant in patients with serious liver diseases, bypassing long waiting lists for organs and concerns about immune system rejection of donated tissue."Our findings provide a foundation for producing functional liver cells for patients who suffer liver diseases and are in need of transplantation," says Yoon-Young Jang, assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center. "iPSC-derived liver cells not only can be generated in large amounts, but also can be tailored to each patient, preventing immune-rejection problems associated with liver transplants from unmatched donors or embryonic stem cells." A microsopic view shows human embryonic stem cells in various stages of differentiation into liver cells in this photo taken at Stanford University and released by the California Institute for Regenerative Medicine, March 9, 2009iPSCs are made from adult cells that have been genetically reprogrammed to revert to an embryonic stem cell-like state, with the ability to transform into different cell types. Human iPSCs can be generated from various tissues, including skin, blood and liver cells.Although the liver can regenerate in the body, end-stage liver failure caused by diseases like cirrhosis and cancers eventually destroy the liver's regenerative ability, Jang says. Currently, the only option for those patients is to receive a liver organ or liver cell transplant, a supply problem given the severe shortage of donor liver tissue for transplantation. In addition, mature liver cells and adult liver stem cells are difficult to isolate or grow in the laboratory, she says. By contrast, iPSCs can be made from a tiny amount of many kinds of tissue; and the embryonic stem- like iPSCs can grow in laboratory cultures indefinitely.For the study, Jang and colleagues generated human iPSCs from a variety of adult human cells, including liver cells, fibroblasts ( connective tissue cells), bone marrow stem cells and skin cells. They found that though the iPSCs overall were molecularly similar to each other and to embryonic stem cells, they retained a distinct molecular "signature" inherited from the cell of origin.

CHENGDU, May 8 (Xinhua) -- As a brand-name herbal capsule for cardiovascular disease in China, Di'ao Xinxuekang only needs to wait for another 15 years before reaching the EU market."The Dutch medical supervisors have recognized it as a qualified drug, but we still lack the evidence of 15-year presence in the EU market," said Ji Jianxin, a research manager with the drug's developer Di'ao Group based in southwest China's Sichuan Province.Di'ao, one of the largest Traditional Chinese Medicine (TCM) manufacturers, has been quite depressed, as many other TCM enterprises in China, by a European Union directive on traditional herbal medicinal products fully implemented from the beginning of this month.The directive requires that all herbal medicinal products, must obtain a medical license from any EU member state before it can be allowed in the EU market.It introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian ones.However, not a single Chinese herbal medicinal product has been granted the license so far, mainly due to the prohibitive registration cost and lack of required evidence to prove the product had a 30-year history of safe use, including 15 years in the EU.With a history of more than 2,000 years, TCM did not enter into the EU market until mid-1990s, and it has been imported into the EU and sold to European customers as food supplements instead of drugs.Most Chinese producers and importers did not reserve the customs papers a decade ago, thus unable to prove the 15-year use of their products in European markets.While TCM's globalization won't be doomed by one single EU directive as TCM export value to EU only takes up 14 percent of the total in 2010, experts and industry insiders still have had serious concerns about its future."Most TCM even don't have standardized labels that can help consumers to find out its origin," said Xian Sheng, from the China Association of TCM Export Companies.
BEIJING, Feb. 27 (Xinhua) -- Chinese Premier Wen Jiabao said during an online chat with netizens here Sunday that the government is striving to ensure that the people live a comfortable life with security and confidence in the period of 2011-2015.China's development blueprint for the coming five years will place high emphasis on the efforts to improve the people's livelihood, Wen said.To enhance the people's living standards is "our work's starting point as well as the final aim," he said.Greater efforts will be made to boost social development and progress, especially in those key sectors and aspects concerning national development and mass interests, the premier said.Wen began his online chat with netizens at 9 a.m. Sunday jointly hosted by the central government website (www.gov.cn) and Xinhua News Agency website (www.news.cn).
SUVA, March 14 (Xinhua) -- Some 300 diabetes patients undergo amputations every year in Fiji and the trend is worrying the authorities.This is according to research carried out by the country's Physiotherapy Associations which shows that majority of these amputations occur in the 40 to 60 age group, physiotherapist Lusia Tikolevu told radio FijiVillage website on Monday.Tikolevu said that they are trying to formulate a protocol for physicist to better understand diabetes in Fiji.A visit to the Colonial War Memorial Hospital in Fiji's capital city of Suva by Xinhua reporter reveals the increasing number of bed ridden patients affected by diabetes in wards.Tikolevu said that diabetes is a prevalent disease and needs the involvement of the whole community for a successful preventative measures.Shocking figures show four out of every 10 people in Fiji have diabetes, putting it amongst the highest in the world.The Fred Hollows Foundation in New Zealand that completed the first survey of its kind in Fiji also showed the diabetic rate in the island nation is four times more than in New Zealand.The survey across 34 communities in Fiji found 40 percent of the people have diabetes."When we found out that 40 percent of the population had diabetes the scope and the depth of the problem just hit us. The impact in terms of costs family aspects, economic issues its just going to be staggering," says Doctor Tom Schaefer from the New Zealand foundation.The survey results also showed a third of those with diabetes did not know they had the disease and women were almost twice as likely as men to have it.The magnitude of the problem is worrying for a health system which has committed staff but little resources."The cost of medication alone is going to outstrip the ability of any health system to do it," says Schaefer.The existence of the sugar cane industry in the island nation may be a contributing factor to the high level of diabetics.
来源:资阳报